Predictive Oncology Inc. (POAI)
NASDAQ: POAI · Real-Time Price · USD
4.260
-1.220 (-22.26%)
At close: Dec 5, 2025, 4:00 PM EST
4.840
+0.580 (13.62%)
After-hours: Dec 5, 2025, 7:54 PM EST

Predictive Oncology Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
14513246213
Upgrade
Market Cap Growth
236.19%-59.10%-44.64%-61.32%382.16%26.38%
Upgrade
Enterprise Value
1655-12218
Upgrade
Last Close Price
4.2612.3049.3591.98285.57219.72
Upgrade
PS Ratio
1.443.378.2116.0443.9410.34
Upgrade
PB Ratio
--26.981.621.111.554.90
Upgrade
P/TBV Ratio
--1.671.122.12-
Upgrade
EV/Sales Ratio
9.712.952.83-15.2614.39
Upgrade
Debt / Equity Ratio
-0.02-10.520.330.010.022.22
Upgrade
Asset Turnover
0.310.170.080.040.050.07
Upgrade
Inventory Turnover
3.141.911.341.241.441.87
Upgrade
Quick Ratio
0.000.412.285.778.810.10
Upgrade
Current Ratio
0.010.622.556.029.090.16
Upgrade
Return on Equity (ROE)
--269.18%-80.02%-82.98%-91.62%-373.13%
Upgrade
Return on Assets (ROA)
-128.80%-70.52%-37.72%-27.46%-29.63%-44.04%
Upgrade
Return on Capital (ROIC)
--105.79%-45.98%-30.25%-33.91%-61.74%
Upgrade
Return on Capital Employed (ROCE)
14.40%-793.20%-115.80%-69.90%-33.20%-335.30%
Upgrade
Earnings Yield
-583.37%-231.66%-104.61%-106.59%-31.49%-199.94%
Upgrade
FCF Yield
-54.57%-218.87%-98.83%-52.97%-21.02%-96.99%
Upgrade
Buyback Yield / Dilution
-76.22%-35.84%-8.92%-34.34%-359.21%-
Upgrade
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q